secwatch.observer — SEC 8-K summary
======================================

Issuer:     BriaCell Therapeutics Corp. (BCTX)
CIK:        0001610820
Form:       8-K
Filed at:   2024-12-16T23:59:59+00:00
Accession:  0001493152-24-050212
Event type: other_material
Sentiment:  negative
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BriaPro reports Q1 net loss of $82K; cash at $1; going concern uncertainty
--------------------------------------------------------------------------

- Net loss $82,123 for three months to Oct 2024 vs $128,026 loss in prior year period.
- Total assets $195,979; intangible assets (patents) net $195,978.
- Current liabilities $522,835; shareholders' deficit $487,817; cash unchanged at $1.
- Due to BriaCell (related party) $503,709; no revenue or commercial operations.
- Going concern doubt due to pre-clinical stage and need for additional financing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610820/000149315224050212/0001493152-24-050212-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610820/000149315224050212/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-050212

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer